Krystal Biotech, Inc.
public$KRYS View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $KRYS
View full $KRYS trading history →Insider Trades (Form 4)
SELLEVP, General Counsel
Thomas John Charles
$526,5202,000 shares Jun 26, 2026
SELLPresident, R&D
Krishnan Suma
$7,702,82525,000 shares Jun 5, 2026
SELLPresident and CEO
Krishnan Krish S
$7,702,98425,000 shares Jun 5, 2026
Key People
Thomas John Charles
EVP, General Counsel
Insider
Krishnan Suma
President, R&D
BoardInsider
Krishnan Krish S
President and CEO
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro